Determining disease activity in inflammatory bowel disease.

Area of Science:

• Gastroenterology
• Clinical Chemistry
• Immunology

Background:

• Clinical assessment of inflammatory bowel disease (IBD) activity can be subjective.
• Objective laboratory markers are needed to correlate with disease severity in ulcerative colitis and Crohn's disease.

Purpose of the Study:

• To evaluate laboratory markers for assessing disease activity in IBD.
• To establish a reliable index for monitoring treatment efficacy.

Main Methods:

• Studied hemoglobin, sedimentation rate, serum albumin, and seromucoid levels in IBD patients.
• Correlated 10 laboratory variables in Crohn's disease patients.
• Utilized factor analysis to develop a disease activity index.

Main Results:

• Serum albumin and seromucoid levels clearly differentiated between active disease and remission.
• Hemoglobin and sedimentation rates showed significant overlap between disease states.
• A strong correlation (r=0.71) was found between serum albumin and seromucoid levels.
• Albumin and seromucoids correlated with other laboratory variables, indicating disease activity.

Conclusions:

• Serum albumin and seromucoid levels are key indicators of disease activity in IBD.
• A simple index using hemoglobin, albumin, and seromucoid values can reliably assess disease status.
• These markers can guide therapeutic regimens and routine follow-up for inflammatory bowel disease.